Patrick Baeuerle
CIK 1362054 · View on SEC EDGAR ↗
First SEC filing: Jan. 7, 2021 · Latest: Jan. 7, 2021
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 8, 2021 | CGEM | S 10b5-1 | 11,000 | $28.45 | $312,950 | 0 Direct | -100.00% | Disposed | -23.5% (price as of 2026-08-20) |
| Aug. 10, 2021 | CGEM | S 10b5-1 | 11,000 | $27.00 | $297,000 | 0 Direct | -100.00% | Disposed | -19.4% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 17, 2023 | CGEM | Stock Option (Right to Buy) | Common Stock (77,000) | $11.34 | Feb. 16, 2033 | 77,000 | Acquired |
| Feb. 11, 2022 | CGEM | Stock Option (Right to Buy) | Common Stock (75,000) | $13.60 | Feb. 10, 2032 | 75,000 | Acquired |
| Sept. 8, 2021 | CGEM | Stock Option (Right to Buy) | Common Stock (11,000) | $4.30 | Oct. 28, 2030 | 11,000 | Disposed |
| Aug. 10, 2021 | CGEM | Stock Option (Right to Buy) | Common Stock (11,000) | $4.30 | Oct. 28, 2030 | 11,000 | Disposed |
| Jan. 7, 2021 | CGEM | Stock Option (Right to Buy) | Common Stock (286,665) | $21.00 | Jan. 6, 2031 | 286,665 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 3 holdings
Securities held when first becoming an insider, per SEC Form 3.
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CGEM
Ph.D. Chief Scientific Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2022 | $463,500 | $266,234 | — | — | — | — | $34,000 | $1,959,984 |
| 2021 | $450,000 | $218,000 | — | — | — | — | $34,800 | $4,675,977 |
| 2020 | $436,997 | $266,131 | — | — | — | — | $34,800 | $5,353,496 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.